I think there might be a way to accelerate the vaccine hesitant to get vaccinated. Give them an alternative to the new mRNA technology that Pfizer, Moderna and J&J offer that, while these vaccines are seemingly effective, the long term impact these vaccines or this mRNA technology might have is unknown.
Apparently Novavax is very close to having their Covid vaccine ready to go.
The basic technology behind NVX-CoV2373 has been used since the mid-1980s, The Atlantic reported, in vaccines for hepatitis B and whooping cough using actual bits of viral material to trigger antibodies. "Protein-subunit vaccines are considered the safest form of vaccines, based on a widely used technology," University of California Berkeley head of infectious diseases Lee Riley said in June.
Pfizer and Moderna's vaccine uses a new type of vaccine technology called mRNA - the first to have made it out of the trial phase. Their vaccines don't contain any viral material at all, instead using a piece of code which teaches our cells how to make the spike proteins themselves.
In its trials, NVX-CoV2373 performed very well - it offered 90 percent protection against symptomatic infection and not a single person amongst those who received it in the phase 3 trial developed severe disease.
It also worked well against the Alpha variant, which was dominant in the US and Mexico at the time the trial took place. It didn't do so well against Beta in South Africa when it came to stopping infection, but it still successfully prevented serious illness.
Real-world data on its efficacy against Delta isn't available yet, but Novavax's latest lab tests suggest it offers some protection - whether it's more or less than the reduced efficacy of the already widely used vaccines remains to be seen.
The Novavax vaccine appeared to trigger fewer mild-to-moderate side effects in its trials than Pfizer.
The known side effects to date are typical of any vaccine - headaches, muscle pain and tiredness amongst them.
Perhaps the vaccine hesitant would not be so hesitant if the had a more traditional vaccine available to them. I think there has been more than enough testing that the FDA could grant an EUA for this vaccine. I guess the question I have is why has this not happened yet. I know, follow the money. BTW, the CDC announced recently that Novavax trial participants can be considered fully vaccinated two weeks after completing their two-dose vaccine regimen.
While anecdotal, I have had a number of unvaccinated people tell that if the vaccine was available to them they would take it in a heartbeat.
As always do your own research. I would be interested in what others thing about the Novavax vaccine.
By the way my daughter asked her doctor about this vaccine and I asked one of my doctors about this vaccine. We received identical answers. "Never heard of it". That was pretty surprising to me.
Apparently Novavax is very close to having their Covid vaccine ready to go.
The basic technology behind NVX-CoV2373 has been used since the mid-1980s, The Atlantic reported, in vaccines for hepatitis B and whooping cough using actual bits of viral material to trigger antibodies. "Protein-subunit vaccines are considered the safest form of vaccines, based on a widely used technology," University of California Berkeley head of infectious diseases Lee Riley said in June.
Pfizer and Moderna's vaccine uses a new type of vaccine technology called mRNA - the first to have made it out of the trial phase. Their vaccines don't contain any viral material at all, instead using a piece of code which teaches our cells how to make the spike proteins themselves.
In its trials, NVX-CoV2373 performed very well - it offered 90 percent protection against symptomatic infection and not a single person amongst those who received it in the phase 3 trial developed severe disease.
It also worked well against the Alpha variant, which was dominant in the US and Mexico at the time the trial took place. It didn't do so well against Beta in South Africa when it came to stopping infection, but it still successfully prevented serious illness.
Real-world data on its efficacy against Delta isn't available yet, but Novavax's latest lab tests suggest it offers some protection - whether it's more or less than the reduced efficacy of the already widely used vaccines remains to be seen.
The Novavax vaccine appeared to trigger fewer mild-to-moderate side effects in its trials than Pfizer.
The known side effects to date are typical of any vaccine - headaches, muscle pain and tiredness amongst them.
Perhaps the vaccine hesitant would not be so hesitant if the had a more traditional vaccine available to them. I think there has been more than enough testing that the FDA could grant an EUA for this vaccine. I guess the question I have is why has this not happened yet. I know, follow the money. BTW, the CDC announced recently that Novavax trial participants can be considered fully vaccinated two weeks after completing their two-dose vaccine regimen.
While anecdotal, I have had a number of unvaccinated people tell that if the vaccine was available to them they would take it in a heartbeat.
As always do your own research. I would be interested in what others thing about the Novavax vaccine.
By the way my daughter asked her doctor about this vaccine and I asked one of my doctors about this vaccine. We received identical answers. "Never heard of it". That was pretty surprising to me.
Comment